Annual Cash & Cash Equivalents
$278.60 M
-$47.84 M-14.66%
31 December 2023
Summary:
ADC Therapeutics SA annual cash & cash equivalents is currently $278.60 million, with the most recent change of -$47.84 million (-14.66%) on 31 December 2023. During the last 3 years, it has fallen by -$160.60 million (-36.57%). ADCT annual cash & cash equivalents is now -40.28% below its all-time high of $466.54 million, reached on 31 December 2021.ADCT Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$274.27 M
-$25.85 M-8.61%
30 September 2024
Summary:
ADC Therapeutics SA quarterly cash and cash equivalents is currently $274.27 million, with the most recent change of -$25.85 million (-8.61%) on 30 September 2024. Over the past year, it has dropped by -$36.13 million (-11.64%). ADCT quarterly cash and cash equivalents is now -48.27% below its all-time high of $530.19 million, reached on 30 September 2021.ADCT Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADCT Cash And Cash Equivalents Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -14.7% | -11.6% |
3 y3 years | -36.6% | -48.3% |
5 y5 years | +100.7% | +137.4% |
ADCT Cash And Cash Equivalents High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -40.3% | at low | -48.3% | +17.1% |
5 y | 5 years | -40.3% | +141.1% | -48.3% | +137.4% |
alltime | all time | -40.3% | +141.1% | -48.3% | +137.4% |
ADC Therapeutics SA Cash And Cash Equivalents History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $274.27 M(-8.6%) |
June 2024 | - | $300.12 M(+28.1%) |
Mar 2024 | - | $234.28 M(-15.9%) |
Dec 2023 | $278.60 M(-14.7%) | $278.60 M(-10.2%) |
Sept 2023 | - | $310.41 M(-10.7%) |
June 2023 | - | $347.51 M(+11.9%) |
Mar 2023 | - | $310.55 M(-4.9%) |
Dec 2022 | $326.44 M(-30.0%) | $326.44 M(-14.3%) |
Sept 2022 | - | $380.86 M(+1.1%) |
June 2022 | - | $376.78 M(-12.6%) |
Mar 2022 | - | $430.87 M(-7.6%) |
Dec 2021 | $466.54 M | $466.54 M(-12.0%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $530.19 M(+42.6%) |
June 2021 | - | $371.88 M(-2.9%) |
Mar 2021 | - | $383.12 M(-12.8%) |
Dec 2020 | $439.19 M(+280.1%) | $439.19 M(-11.2%) |
Sept 2020 | - | $494.42 M(+41.8%) |
June 2020 | - | $348.59 M(+201.7%) |
Dec 2019 | $115.55 M(-16.8%) | - |
Dec 2019 | - | $115.55 M(-36.6%) |
June 2019 | - | $182.16 M(+31.2%) |
Dec 2018 | $138.81 M(-47.2%) | - |
Dec 2018 | - | $138.81 M |
Dec 2017 | $262.75 M(+82.9%) | - |
Dec 2016 | $143.67 M | - |
FAQ
- What is ADC Therapeutics SA annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ADC Therapeutics SA?
- What is ADC Therapeutics SA annual cash & cash equivalents year-on-year change?
- What is ADC Therapeutics SA quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ADC Therapeutics SA?
- What is ADC Therapeutics SA quarterly cash and cash equivalents year-on-year change?
What is ADC Therapeutics SA annual cash & cash equivalents?
The current annual cash & cash equivalents of ADCT is $278.60 M
What is the all time high annual cash & cash equivalents for ADC Therapeutics SA?
ADC Therapeutics SA all-time high annual cash & cash equivalents is $466.54 M
What is ADC Therapeutics SA annual cash & cash equivalents year-on-year change?
Over the past year, ADCT annual cash & cash equivalents has changed by -$47.84 M (-14.66%)
What is ADC Therapeutics SA quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of ADCT is $274.27 M
What is the all time high quarterly cash and cash equivalents for ADC Therapeutics SA?
ADC Therapeutics SA all-time high quarterly cash and cash equivalents is $530.19 M
What is ADC Therapeutics SA quarterly cash and cash equivalents year-on-year change?
Over the past year, ADCT quarterly cash and cash equivalents has changed by -$36.13 M (-11.64%)